Epidemiology and Management of Cutaneous T-Cell Lymphoma at Hospital México, Costa Rica.
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Clinical Trials Related to T-cell Lymphoma
Related studies linked through entity extraction aliases.
Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma
- Status
- SUSPENDED
- Phase
- PHASE1
Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Enasidenib in People With T-Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing
- Status
- RECRUITING
- Phase
- N/A
Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
- Status
- RECRUITING
- Phase
- PHASE2
Treatment of Relapsed or Refractory Epstein-Barr Virus Positive T-cell Lymphoma With hNeo-T
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
- Status
- RECRUITING
- Phase
- N/A
Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Study of Tazemetostat in Lymphoid Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
A Registry for People With T-cell Lymphoma
- Status
- RECRUITING
- Phase
- N/A
A Study in Adults With Cutaneous T-cell Lymphoma (CTCL) Retreated With Brentuximab Vedotin
- Status
- COMPLETED
- Phase
- N/A
A Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Brentuximab Vedotin Treatment in Chinese Adults With CD30-Positive Cutaneous T-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE4
Intravenous Injection of Oncolytic Virus Injection (RT-01) in Patients With Relapsed or Refractory T-cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1
Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Tucidinostat, Azacitidine Combined With CHOP Versus CHOP in Patients With Untreated Peripheral T-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE3
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of CD4-Targeted Chimeric Antigen Receptor T-Cells (CD4- CAR-T) in Subjects With Relapsed or Refractory T-Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Duvelisib Maintenance After Autologous Stem Cell Transplant in T-Cell Lymphomas
- Status
- TERMINATED
- Phase
- PHASE2